NNC0143-0406

· Novo Nordisk A/S

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for NNC0143-0406, covering 2017-12-06 to 2018-02-26. Get the full timeline:

Most recent: Clinical Trial Update: A Randomised Proof-of-Principle Trial Investigating Pharmacodynamics, Pharmacokinetics, and Safety of NNC0143-0406 in Subjects With Type 1 Diabetes Mellitus [Phase 1]

See pricing